Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate [PDF]
Clinical Kidney Journal, 2008 Sir,We recently introduced lanthanum carbonate as an alter-native phosphate binder to sevelamer hydrochloride in pa-tients with elevated serum calcium. Lanthanum carbonatehas a higher affinity for phosphate than sevelamer HCl, sofewer lanthanum carbonate tablets are required to achievethe same phosphate control.
Lindley, Elizabeth +2 more
openaire +2 more sources
PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
PLoS ONE, 2017 The effects of PA21, a novel iron-based and non-calcium-based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease-mineral and bone disorder (CKD-MBD) were evaluated.
Atsushi Yaguchi +3 more
doaj +1 more source
Correction of hyperphosphatemia in hemodialysis patients: 12-month findings from a randomized study
Український Журнал Нефрології та Діалізу, 2022 . The aim of our study was to compare the safety and effectiveness of the use of sevelamer with calcium acetate for hyperphosphatemia control in hemodialysis patients. Materials and methods.
I.O. Dudar +3 more
doaj +1 more source
Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism [PDF]
, 2013 Background: Secondary hyperparathyroidism (SHPT) is one of the common complications in dialysis patients, and is associated with increased risk of vascular calcification.
Akagi, Shigeru +8 more
core +1 more source
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease [PDF]
, 2013 Chronic kidney disease (CKD) patients are given calcium carbonate to bind dietary phosphorus and reduce phosphorus retention, and to prevent negative calcium balance. Data are limited on calcium and phosphorus balance in CKD to support this.
Hill, Kathleen M. +6 more
core +1 more source
Brazilian Registry of Bone Biopsy (REBRABO): design, data elements and methodology [PDF]
, 2014 Introduction: Mineral bone disorder (MBD) is a common condition in chronic kidney disease (CKD) patients and causes significant morbidity and mortality.
Barreto, Fellype Carvalho +11 more
core +5 more sources
Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients
Kidney International Reports, 2018 In this phase III, open-label, single-arm, multi-center 12-week study, we evaluated the efficacy and safety of combination therapy with sucroferric oxyhydroxide (PA21) and calcium carbonate for hemodialysis patients with hyperphosphatemia.
Fumihiko Koiwa +3 more
doaj +1 more source
Kidney Medicine, 2022 Rationale & Objective: There is a concern regarding increased risk of vascular calcification with the use of calcium-based phosphorus binders. This study aimed to compare the effects of sevelamer used as a second-line, low-dose therapy with calcium ...
Angela Yee-Moon Wang, MD, PhD +8 more
doaj +1 more source
Macromolecular Rapid Communications, EarlyView.We report here a new methodology to prepare functional poly(acetylene)s under aqueous conditions. This methodology is underpinned by poly(O‐propargyl‐N‐amino carbamate) (P1), a reactive poly(acetylene) carrying acyl hydrazines. Thus, P1 reacts with aldehydes to give functional poly(acetylene)s, including cationic, hydrophobic, and sugar‐loaded poly ...
Tom Leigh +8 more
wiley +1 more source
Microbiota signatures in type-2 diabetic patients with chronic kidney disease - A Pilot Study [PDF]
, 2019 The human microbiota is paramount for normal host physiology. Altered host-microbiome interactions are part of the pathogenesis of numerous common ailments.
Chifiriuc, Mariana Carmen +9 more
core +1 more source